Chargement en cours...
Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside
Three inhibitors of type-B monoamine oxidase (MAOB), selegiline, rasagiline, and safinamide, are used for the treatment of Parkinson’s disease (PD). All three drugs improve motor signs of PD, and are effective in reducing motor fluc-tuations in patients undergoing long-term L-DOPA treatment. The eff...
Enregistré dans:
| Publié dans: | Curr Neuropharmacol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Bentham Science Publishers
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7052841/ https://ncbi.nlm.nih.gov/pubmed/30160213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X16666180830100754 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|